Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease

por Ahuja, Manuj, Kaidery, Navneet Ammal, Dutta, Debashis, Attucks, Otis C., Kazakov, Eliot H., Gazaryan, Irina, Matsumoto, Mitsuyo, Igarashi, Kazuhiko, Sharma, Sudarshana M., Thomas, Bobby
Publicado 2022

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons

por Poloznikov, Andrey A., Nersisyan, Stepan A., Hushpulian, Dmitry M., Kazakov, Eliot H., Tonevitsky, Alexander G., Kazakov, Sergey V., Vechorko, Valery I., Nikulin, Sergey V., Makarova, Julia A., Gazaryan, Irina G.
Publicado 2021